More on CATX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+31.4% Growth)
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Perspective Therapeutics (NY:CATX)
Delayed: 2.17 -0.17 (7.26%)
Prev. Close $2.34  
Open$2.34 
52 Wk High$ 
52 Wk Low$ 
Day High$2.34 
Day Low$2.15 
P/E N/A  
EPS$ 
Volume1,669,590 

Friends, Peers and Foes (?): IDYA, JANX, MRUS, NUVL, SMMT (more...)

Oct 16, 2026 10:51 AM RBC: 'ESMO is likely the biggest event for MRK/MRNA for the rest of this year'
Oct 8, 2026 06:28 AM Form 8-K Perspective Therapeutics For: Oct 08
Oct 8, 2026 06:16 AM FDA grants fast track designation to Perspective Therapeutics' PSV359
Oct 1, 2026 04:09 PM Form 8-K Perspective Therapeutics For: Oct 01
Sep 23, 2026 04:20 PM Form SCHEDULE 13D/A Perspective Therapeutics Filed by: Lantheus Holdings, Inc.
Sep 18, 2026 06:05 AM William Blair Starts Perspective Therapeutics Inc (CATX) at Outperform
Sep 14, 2026 06:20 AM Form 8-K Perspective Therapeutics For: Sep 14
Sep 8, 2026 05:17 PM Form 8-K Perspective Therapeutics For: Sep 08
Sep 8, 2026 04:51 PM Form 4 Perspective Therapeutics For: Sep 03 Filed by: Lantheus Holdings, Inc.
Sep 4, 2026 05:01 PM Form 4 Perspective Therapeutics For: Sep 02 Filed by: Lantheus Holdings, Inc.
View All Articles

Entities mentioned with CATX

View All Entities